Indications
Therapeutic Asset Ratings
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Rituximab
Leukemia
University of Chicago
P3
BB
(66)
Rituximab
Primary Mediastinal Large B-Cell Lymphoma
City of Hope Medical Center
P3
BB
(66)
Rivaroxaban
Patent Foramen Ovale
Chinese Academy of Medical Sciences, Fuwai Hospital
P3
BB
(66)
Rivoceranib
Hepatocellular Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
P3
BB
(66)
Rna, (P-Thio)[2?-O-(2-Methoxyethyl)](A-G-M?U-M?U-G-G-A-G-M?C-A-A-G-A-M?U-M?U-A-M?U-M?C)
Dravet Syndrome
Stoke Therapeutics, Inc
P3
BB
(66)
Romidepsin
Acute Myeloid Leukemia With 11q23 Abnormalities
M.D. Anderson Cancer Center
P3
BB
(66)
Sargramostim
Uveal Melanoma
Thomas Jefferson University
P3
BB
(66)
Sargramostim
Cutaneous Melanoma
Mayo Clinic
P3
BB
(66)
Sargramostim
Plasma Cell Myeloma
Roswell Park Cancer Institute
P3
BB
(66)
Sargramostim
Breast Carcinoma
Mayo Clinic
P3
BB
(66)
Semaglutide
Alzheimer Disease
The Methodist Hospital Research Institute
P3
BB
(66)
Serine D-Form
Schizophrenia
University of Minnesota
P3
BB
(66)
Sipuleucel-T
Prostate Cancer
City of Hope Medical Center
P3
BB
(66)
sp-102
Radiculopathy
Semnur Pharmaceuticals, Inc.
P3
BB
(66)
Survodutide
Metabolic Dysfunction-Associated Steatohepatitis
Boehringer Ingelheim
P3
BB
(66)
Tacrolimus
Acute Myeloid Leukemia
City of Hope Medical Center
P3
BB
(66)
Tacrolimus
Plasma Cell Myeloma
Thomas Jefferson University
P3
BB
(66)
Tacrolimus
Mantle Cell Lymphoma
University of Michigan Rogel Cancer Center
P3
BB
(66)
Tas-102
Colorectal Cancer
STCube, Inc.
P3
BB
(66)
Thiotepa
Paroxysmal Nocturnal Hemoglobinuria
Fred Hutchinson Cancer Center
P3
BB
(66)
Thiotepa
Non-Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center
P3
BB
(66)
Tislelizumab
Colorectal Cancer
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
P3
BB
(66)
Tolebrutinib
Relapsing-Remitting Multiple Sclerosis
Sanofi
P3
BB
(66)
tqb3616
Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
P3
BB
(66)
Trastuzumab
Breast Disorder
Incepta Pharmaceuticals Ltd
P3
BB
(66)
Showing 2326 to 2350 of 42,301 assets
Previous
Page 94 of 1693
Next